Cabozantinib as an emerging standard of care in renal cell carcinoma: clarifying the data?
Journal: Proceedings (Baylor University. Medical Center)
Published:
Authors
Relevant Conditions
Similar Publications
We couldn’t find any related articles. Please check for more on the main search page.